Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relay Therapeutics

3.50
-0.0600-1.69%
Volume:2.27M
Turnover:7.96M
Market Cap:600.06M
PE:-1.60
High:3.61
Open:3.57
Low:3.47
Close:3.56
Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Relay Therapeutics (RLAY) and AnaptysBio (ANAB)

TIPRANKS
·
06 May

Relay Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Relay Therapeutics Q1 EPS $(0.46) Beats $(0.48) Estimate, Sales $7.68M Beat $10.00K Estimate

Benzinga
·
06 May

BRIEF-Relay Therapeutics Q1 Net Income USD -77.065 Million

Reuters
·
06 May

Relay Therapeutics Q1 Basic EPS USD -0.46

THOMSON REUTERS
·
06 May

Relay Therapeutics Inc -Cash Runway Extended Into 2029

THOMSON REUTERS
·
06 May

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates

GlobeNewswire
·
06 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 May

Relay Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
03 May

Chief Legal Officer Brian Adams Reports Disposal of Common Shares of Relay Therapeutics Inc

Reuters
·
01 May

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

GlobeNewswire
·
29 Apr

Top Executive Makes Significant Move with Relay Therapeutics Stock

TIPRANKS
·
25 Apr

Relay Therapeutics, Inc. : Wells Fargo Initiates Coverage With Equal Weight Rating and Target Price $4

THOMSON REUTERS
·
17 Apr

Relay Therapeutics initiated with an Equal Weight at Wells Fargo

TIPRANKS
·
17 Apr

Is Relay Therapeutics Inc. (NASDAQ:RLAY) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Insider Monkey
·
16 Apr

Top Cancer Stocks to Buy to Boost Your Portfolio's Health

Zacks
·
16 Apr

Relay Therapeutics (RLAY) Gets Analyst Boost as AI-Driven Drug Discovery Shines!

Insider Monkey
·
31 Mar

Relay Therapeutics weakness brings buying opportunity, says Barclays

TIPRANKS
·
30 Mar

Relay Therapeutics weakness brings buying opportunity, says Barclays

TIPRANKS
·
27 Mar

Relay Therapeutics Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Mar